Search results
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
The Wall Street Journal· 2 hours ago‘People literally talk about how AI is going to cure diseases someday, and I think this is a very...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 1 day agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 18 hours agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - ...
Benzinga· 18 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Fortune via AOL· 7 days agoBrad Miller is helping Moderna shift from its reliance on COVID vaccines, with the company hoping to...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoModerna stock surged — and then tumbled — in mid-April after the company unveiled early-stage test...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) has secured a contract with Brazil's Ministry of Health to supply 12.5...
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 2 days agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
Moderna stock traded in the red for the eighth straight day (NASDAQ:MRNA)
Seeking Alpha· 5 days agoThe stock closed down 0.58% at $101.41. MRNA has lost about 29.6% in the last 12 months and YTD, the...